נולוג'יקס 250 מ"ג
国家: 以色列
语言: 希伯来文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
BELATACEPT 25 MG/ML
可用日期:
BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED
ATC代码:
L04AA28
药物剂型:
POWDER FOR CONCENTRATE FOR INFUSION
给药途径:
I.V
厂商:
BRISTOL-MYERS SQUIBB S.R.L, ITALY
治疗组:
BELATACEPT
疗效迹象:
Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen
授权日期:
2012-08-01
